The resulted ion exchange capacities (IEC) were 0.79 1.87 (mmol g−1) and proton conductivities were evaluated as increasing IEC.
After three days, proliferation was evaluated as increase in the number of viable cells, measured using a bioreduction colorimetric assay.
In the same set of experiments the mRNA and protein level of TIMAP were evaluated as well; interestingly, both increased in the RACK1 depleted HPAEC.
Parameters of angiogenesis were evaluated as above.
LVCR was evaluated as an increase in the peak of an average longitudinal SR, measured in the basal and mid segments of 2 and 4 chamber ventricular walls.
The signal was evaluated as decreased, normal or increased according to location and as compared to controls.
The glomerular expression of ICAM-1 was evaluated as normal, decreased or increased.
One hour after injection, edema was evaluated as the percentage increase in weight of the right paw compared to the left one.
Proliferation was evaluated as cell number increase, and synoviocytes were treated with 0.5 μM and 1 μM RAL with and without urokinase-plasminogen activator (u-PA) and anti-u-PA/anti-u-PA receptor (u-PAR) antibodies.
For more complex mixtures, a two-phase approach was evaluated as a method for increasing the potential for protein identification by UVPD.
